METTL14 enhances m6A modification of SETBP1 mRNA through the formation of METTL3-METTL14 complex, leading to increased stability of SETBP1 mRNA and activation of the PI3K-AKT signaling pathway, ultimately facilitating MDS cell proliferation. Here, METTL3 is linked to myelodysplastic syndrome.